Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-11-17 Sale |
2023-11-20 5:09 pm |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
483,741 | $0 | $0 | 0 (Direct) |
View |
2023-11-17 Sale |
2023-11-20 5:07 pm |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
27,380 | $0 | $0 | 0 (Direct) |
View |
2023-11-17 Sale |
2023-11-20 5:05 pm |
Acer Therapeutics Inc. | ACER | Joseph Donald See Remarks |
14,285 | $0 | $0 | 0 (Direct) |
View |
2023-11-17 Sale |
2023-11-20 5:03 pm |
Acer Therapeutics Inc. | ACER | Schelling Chris PRESIDENT AND CEO 10% Owner |
2,712,529 | $0 | $0 | 0 (Direct) |
View |
2023-11-17 Sale |
2023-11-20 5:03 pm |
Acer Therapeutics Inc. | ACER | PALMIN HARRY S CHIEF FINANCIAL OFFICER |
125,000 | $0 | $0 | 0 (Direct) |
View |
2023-11-17 Sale |
2023-11-20 5:01 pm |
Acer Therapeutics Inc. | ACER | Davis Jefferson E CHIEF BUSINESS OFFICER |
71,645 | $0 | $0 | 0 (Direct) |
View |
2022-11-29 Purchase |
2022-12-01 4:02 pm |
Acer Therapeutics Inc. | ACER | Schelling Chris President & CEO 10% Owner |
819,672 | $1.22 | $1,000,000 | 2,712,529 (Direct) |
View |
2022-11-29 Purchase |
2022-12-01 4:01 pm |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
409,836 | $1.22 | $500,000 | 483,741 (Direct) |
View |
2021-12-09 Purchase |
2021-12-13 4:02 pm |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
10,000 | $2.0622 | $20,622 | 73,905 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-03-14 Option Award |
2023-03-16 4:50 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Quartel Adrian W Chief Medical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:47 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Paul Bernard H Chief People Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:45 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | PALMIN HARRY S Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:43 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Klopp John Michael Chief Technical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:41 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:39 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Hayden Tanya Chief Operating Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:37 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:35 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:32 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer |
30,000 | $0 | 30,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:30 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-03-14 Option Award |
2023-03-16 4:21 pm |
N/A 2033-03-14 |
Acer Therapeutics Inc. | ACER | Amello Jason Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-19 Option Award |
2022-06-22 4:06 pm |
N/A 2032-06-19 |
Acer Therapeutics Inc. | ACER | Hayden Tanya Chief Operating Officer |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2022-06-22 4:04 pm |
N/A 2031-06-01 |
Acer Therapeutics Inc. | ACER | Hayden Tanya Chief Operating Officer |
0 | $0 | 42,500 (Direct) |
View |
2022-02-21 Option Award |
2022-02-23 4:39 pm |
N/A 2032-02-21 |
Acer Therapeutics Inc. | ACER | Quartel Adrian W Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-21 4:07 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Paul Bernard H Chief People Officer |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2022-01-21 4:04 pm |
N/A 2029-05-08 |
Acer Therapeutics Inc. | ACER | Paul Bernard H Chief People Officer |
0 | $0 | 65,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:32 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Seibt Matthew Chief Commercial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:29 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Schelling Chris President & CEO 10% Owner |
50,000 | $0 | 50,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:28 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | PALMIN HARRY S Chief Opp. and Financial Offr |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:25 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Klopp John Michael Chief Technical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:24 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:22 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director |
18,500 | $0 | 18,500 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:20 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
18,500 | $0 | 18,500 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:18 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:15 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
18,500 | $0 | 18,500 (Direct) |
View |
2022-01-14 Option Award |
2022-01-19 4:10 pm |
N/A 2032-01-14 |
Acer Therapeutics Inc. | ACER | Amello Jason Director |
18,500 | $0 | 18,500 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:50 pm |
N/A 2031-02-03 |
Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2021-02-05 4:47 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | Davis Jefferson E Chief Business Officer |
0 | $0 | 76,645 (Direct) |
View |
2021-01-15 Option Award |
2021-01-20 4:23 pm |
N/A 2031-01-15 |
Acer Therapeutics Inc. | ACER | Seibt Matthew Chief Commercial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
2021-01-15 Option Award |
2021-01-20 4:21 pm |
N/A 2031-01-15 |
Acer Therapeutics Inc. | ACER | Schelling Chris President & CEO 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |